You are here

  • Home
  • Archive
  • Volume 81, Issue 10
  • Response to: ‘Correspondence on ‘Interleukin-6 blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study’ by Potere et al’ by Buckley

Article metrics

Article menu
Download PDFPDF
Correspondence response
Response to: ‘Correspondence on ‘Interleukin-6 blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case–control study’ by Potere et al’ by Buckley

 

Online download statistics by month:

Online download statistics by month: September 2020 to March 2024

AbstractFullPdf
Sep 2020556468121
Oct 202013414222
Nov 2020384018
Dec 202034348
Jan 202148478
Feb 2021121212
Mar 202116169
Apr 202117175
May 202166689
Jun 202121214
Jul 2021272812
Aug 2021292711
Sep 2021302811
Oct 2021363618
Nov 2021363821
Dec 202185858
Jan 202242425
Feb 202226266
Mar 202232324
Apr 202226266
May 2022333413
Jun 202224245
Jul 202224241
Aug 2022727211
Sep 202228828920
Oct 202210410417
Nov 202240408
Dec 202212125
Jan 2023333110
Feb 202337377
Mar 202320204
Apr 20234800
May 20236911
Jun 20233400
Jul 20232611
Aug 20231800
Sep 20234600
Oct 20235900
Nov 20233410
Dec 20233800
Jan 20243700
Feb 20243411
Mar 20241511
Total24561925423